Inventory Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual inventory in 2023 was 53.33 Million USD , down -11.02% from previous year.
Genscript Biotech Corporation's latest quarterly inventory in 2024 Q2 was 50.85 Million USD , down -0.04% from previous quarter.
Genscript Biotech Corporation reported annual inventory of 59.93 Million USD in 2022, up 35.12% from previous year.
Genscript Biotech Corporation reported annual inventory of 44.35 Million USD in 2021, up 39.73% from previous year.
Genscript Biotech Corporation reported quarterly inventory of 50.85 Million USD for 2024 Q2, down -0.04% from previous quarter.
Genscript Biotech Corporation reported quarterly inventory of 51.51 Million USD for 2023 Q1, down -14.05% from previous quarter.

Annual Inventory Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Inventory of Genscript Biotech Corporation (2023 - 2013)

Year	Inventory	Inventory Growth
2023	53.33 Million USD	-11.02%
2022	59.93 Million USD	35.12%
2021	44.35 Million USD	39.73%
2020	31.74 Million USD	59.88%
2019	19.85 Million USD	59.75%
2018	12.42 Million USD	80.71%
2017	6.87 Million USD	62.33%
2016	4.23 Million USD	109.23%
2015	2.02 Million USD	13.96%
2014	1.77 Million USD	26.57%
2013	1.4 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	50.85 Million USD	-4.64%
2024 Q2	50.85 Million USD	-0.04%
2023 Q1	51.51 Million USD	-14.05%
2023 Q3	53.34 Million USD	3.55%
2023 Q2	51.51 Million USD	0.0%
2023 FY	53.33 Million USD	-11.02%
2023 Q4	53.33 Million USD	-0.03%
2022 Q4	59.93 Million USD	0.0%
2022 Q3	59.93 Million USD	20.12%
2022 Q2	49.89 Million USD	0.0%
2022 Q1	49.89 Million USD	12.49%
2022 FY	59.93 Million USD	35.12%
2021 Q3	44.35 Million USD	27.15%
2021 Q4	44.35 Million USD	0.0%
2021 Q2	34.88 Million USD	0.0%
2021 Q1	34.88 Million USD	9.89%
2021 FY	44.35 Million USD	39.73%
2020 Q3	31.74 Million USD	31.29%
2020 FY	31.74 Million USD	59.88%
2020 Q1	24.17 Million USD	21.78%
2020 Q2	24.17 Million USD	0.0%
2020 Q4	31.74 Million USD	0.0%
2019 Q4	19.85 Million USD	20.44%
2019 Q3	16.48 Million USD	11.97%
2019 Q2	14.72 Million USD	0.0%
2019 Q1	14.72 Million USD	18.46%
2019 FY	19.85 Million USD	59.75%
2018 Q3	12.42 Million USD	53.98%
2018 Q1	8.07 Million USD	17.36%
2018 Q2	8.07 Million USD	0.0%
2018 Q4	12.42 Million USD	0.0%
2018 FY	12.42 Million USD	80.71%
2017 Q3	6.87 Million USD	23.55%
2017 FY	6.87 Million USD	62.33%
2017 Q4	6.87 Million USD	0.0%
2017 Q2	5.56 Million USD	0.0%
2017 Q1	5.56 Million USD	31.39%
2016 Q3	4.23 Million USD	-0.73%
2016 Q4	4.23 Million USD	0.0%
2016 FY	4.23 Million USD	109.23%
2016 Q2	4.26 Million USD	0.0%
2016 Q1	4.26 Million USD	110.77%
2015 Q3	2.02 Million USD	-5.2%
2015 Q1	2.13 Million USD	20.2%
2015 Q4	2.02 Million USD	0.0%
2015 FY	2.02 Million USD	13.96%
2015 Q2	2.13 Million USD	0.0%
2014 Q1	- USD	0.0%
2014 FY	1.77 Million USD	26.57%
2014 Q4	1.77 Million USD	0.0%
2014 Q3	1.77 Million USD	0.0%
2013 FY	1.4 Million USD	0.0%

Peer Inventory Comparison of Genscript Biotech Corporation

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	-3327.476%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-517531.02%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	-3042.694%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	-2379.386%
Mesoblast Limited	1.00 USD	-5333152300.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	40.345%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	56468.668%
Marizyme, Inc.	24.85 Thousand USD	-214470.606%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-333222.025%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-5333152300.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-6702.49%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	-3016.98%
Neon Bloom, Inc.	7938.00 USD	-671750.894%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	6.04%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-236151.989%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	-3808.492%
IMV Inc.	2.00 USD	-2666576100.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-444329.367%
Curative Biotechnology, Inc.	-115.62 Thousand USD	46224.561%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-58886.566%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	99.106%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	-2149.326%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-25345.765%
argenx SE	310.55 Million USD	82.827%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-462847.257%
Zenith Capital Corp.	3.00 USD	-1777717366.667%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-106563.048%
WPD Pharmaceuticals Inc.	0.25 USD	-21332609500.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	-159.258%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	-315.419%
Cotinga Pharmaceuticals Inc.	0.98 USD	-5441992144.898%
BioStem Technologies, Inc.	658.67 Thousand USD	-7996.752%
ONE Bio Corp.	4.5 Million USD	-1083.775%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-5333152300.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	258101.664%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	612302327.325%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	-4122.607%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	-255.543%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-5333152300.0%
IntelGenx Technologies Corp.	71 Thousand USD	-75014.823%
Gelesis Holdings, Inc.	6.86 Million USD	-676.861%
CSL Limited	5.96 Billion USD	99.106%
Cellectis S.A.	1.00 USD	-5333152300.0%

Global Stocks Search

Genscript Biotech Corporation (GNNSF)

Inventory Summary of Genscript Biotech Corporation

Annual Inventory Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Inventory of Genscript Biotech Corporation (2023 - 2013)

Peer Inventory Comparison of Genscript Biotech Corporation